SAREPTA THERAPEUTICS INC (SRPT)
US8036071004 - Common Stock
| TTM (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | 16.97M | -535.98M | -703.50M | -418.80M | -554.10M | |||
| Depreciation Amortization | 41.84M | 44.40M | 41.90M | 38.00M | 26.90M | |||
| Change In Working Capital | -681.60M | -481.09M | -39.50M | -98.20M | 554.10M | |||
| Interest Paid | 16.11M | 15.92M | 44.40M | 55.90M | 34.40M | |||
| Taxes Paid | N/A | 15.08M | 1.70M | 600.00K | 2.50M | |||
| Other non cash items | 89.25M | 471.68M | 375.70M | 35.80M | 80.60M | |||
| OPERATING CASH FLOW | -533.67M | -500.99M | -325.30M | -443.20M | 107.50M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -120.19M | -87.34M | -33.30M | -42.60M | -85.70M | |||
| Other Investing Activity | 160.68M | -78.46M | -1.01B | 538.00M | -36.00M | |||
| INVESTING CASH FLOW | 40.49M | -165.80M | -1.05B | 495.40M | -121.70M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | 0.00 | 304.20M | 0.00 | 291.20M | |||
| Stock Issued/Repurchased | 45.33M | 131.89M | -70.90M | 569.30M | 396.00M | |||
| Other Financing Activity | 13.00K | -6.89M | -700.00K | -7.80M | -4.80M | |||
| FINANCING CASH FLOW | 45.34M | 125.00M | 232.50M | 561.60M | 682.30M | |||
| CHANGE IN CASH | -447.83M | -541.79M | -1.14B | 613.80M | 668.10M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -533.67M | -500.99M | -325.30M | -443.20M | 107.50M | |||
| Capital Expenditure | -120.19M | -87.34M | -33.30M | -42.60M | -85.70M | |||
| FREE CASH FLOW | -653.86M | -588.34M | -358.60M | -485.80M | 21.80M | |||
All data in USD